Regional supply

Exosome and Protocol Supply by Region

ExaVeyra Sciences is a Miami-based B2B supplier of research-use exosomes to licensed clinics, and it refers licensed prescribers to a 503A compounding pharmacy that prepares formulations against individual prescriptions.

Exosome material ships to licensed practices in every state and Puerto Rico. Compounded 503A preparations are dispensed by the pharmacy partner against individual prescriptions where it holds a non-resident license, which the marker beside each state records. Each region page says what a practice there can source, how it arrives, and where the state law is answered; none of them changes what the material is.

Regions

11 of 99 published. The remainder are in review and will appear as they are completed.

Alabamaexosome material

  • Birmingham and Mountain Brook in review

Arizonaexosomes and compounded

  • Scottsdale
  • Paradise Valley in review
  • Phoenix in review
  • Tucson in review

Californiaexosome material

  • Calabasas
  • Malibu
  • Newport Beach
  • Beverly Hills in review
  • La Jolla and San Diego in review
  • Los Angeles in review
  • Palo Alto and Atherton in review
  • San Francisco and Marin in review
  • Laguna Beach and Dana Point in review
  • Carlsbad and Rancho Santa Fe in review
  • Carmel and Pebble Beach in review
  • Huntington Beach in review

Coloradoexosomes and compounded

  • Aspen
  • Boulder in review
  • Denver and Cherry Hills in review
  • Vail in review
  • Beaver Creek and Avon in review

Connecticutexosomes and compounded

  • Greenwich in review
  • Westport in review

District of Columbiaexosomes and compounded

  • Washington DC in review

Floridaexosomes and compounded

Georgiaexosomes and compounded

  • Atlanta and Buckhead in review
  • Alpharetta in review
  • Savannah in review

Hawaiiexosome material

  • Honolulu in review
  • Maui and Wailea in review

Idahoexosomes and compounded

  • Boise in review
  • Sun Valley and Ketchum in review

Illinoisexosomes and compounded

  • Chicago and the North Shore in review
  • Naperville in review

Indianaexosomes and compounded

  • Indianapolis and Carmel in review

Iowaexosomes and compounded

  • Des Moines in review

Kansasexosomes and compounded

  • Overland Park in review

Louisianaexosomes and compounded

  • New Orleans in review
  • Baton Rouge in review

Maineexosomes and compounded

  • Bar Harbor and Mount Desert Island in review

Marylandexosome material

  • Bethesda and Chevy Chase in review
  • Potomac in review

Massachusettsexosome material

  • Boston and Wellesley in review
  • Nantucket and Martha's Vineyard in review

Michiganexosomes and compounded

  • Bloomfield Hills and Birmingham in review

Minnesotaexosome material

  • Minneapolis, Edina and Wayzata in review

Missouriexosomes and compounded

  • Kansas City in review
  • St. Louis and Ladue in review

Montanaexosomes and compounded

  • Big Sky and Bozeman in review

Nevadaexosomes and compounded

  • Henderson in review
  • Las Vegas and Summerlin in review
  • Reno and Incline Village in review

New Jerseyexosomes and compounded

  • Princeton in review
  • Short Hills and Bergen County in review

New Yorkexosomes and compounded

  • The Hamptons and Long Island in review
  • Manhattan in review
  • Brooklyn in review
  • Westchester in review

North Carolinaexosome material

  • Charlotte in review
  • Raleigh and Chapel Hill in review

Ohioexosomes and compounded

  • Cleveland in review
  • Columbus in review

Oklahomaexosomes and compounded

  • Oklahoma City in review
  • Tulsa in review

Oregonexosome material

  • Portland and Lake Oswego in review

Pennsylvaniaexosomes and compounded

  • Philadelphia and the Main Line in review

Puerto Ricoexosomes and compounded

  • Dorado in review
  • San Juan and Condado in review

South Carolinaexosome material

  • Charleston in review
  • Hilton Head in review
  • Myrtle Beach in review

Tennesseeexosome material

  • Franklin and Brentwood in review
  • Nashville in review

Texasexosomes and compounded

  • Dallas and Highland Park
  • Austin in review
  • Fort Worth and Southlake in review
  • Houston and River Oaks in review
  • San Antonio in review

Utahexosomes and compounded

  • Park City in review
  • Salt Lake City in review

Virginiaexosome material

  • McLean and Great Falls in review
  • Richmond in review

Washingtonexosomes and compounded

  • Bellevue and Medina in review
  • Seattle in review

Wisconsinexosomes and compounded

  • Milwaukee in review

Wyomingexosomes and compounded

  • Jackson Hole in review

Nothing on this page has been reviewed or approved by the FDA. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A against a prescription for an individual patient and dispensed by the pharmacy, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances.

This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.

Reference only. Not legal or medical advice.

The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.

Read the full disclaimer

ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.

No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.

Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.

The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.